<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04929509</url>
  </required_header>
  <id_info>
    <org_study_id>P11-4 in white spot lesions</org_study_id>
    <nct_id>NCT04929509</nct_id>
  </id_info>
  <brief_title>P11-4 and Nanosilver Fluoride Varnish in Treatment of White Spot Carious Lesions</brief_title>
  <official_title>Effectiveness of Self-assembling Peptide (P11-4) and Nano-silver Fluoride Varnish in Management of Enamel White Spot Lesions in Young People (Randomized Controlled Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hams Hamed Abdelrahman</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Great efforts have been undertaken for dental caries prevention. Among the recent&#xD;
      remineralizing materials, Nano silver fluoride varnish products which are based on&#xD;
      nanotechnology have been proposed for &quot;repairing&quot; enamel . Regenerative medicine-based&#xD;
      approaches for caries treatment focus on biomimetic remineralization of initial carious&#xD;
      lesions as a minimal invasive therapy using Self-Assembling Peptide P11-4 (Curodont Repair)&#xD;
      which enhances remineralization of white spot lesions. Purpose of the Study: The aim of this&#xD;
      study is to compare clinically and microbiologically the therapeutic effect of Self&#xD;
      Assembling Peptide P11-4 (Curodont Repair), nano silver fluoride varnish and 5% fluoride&#xD;
      varnish (Duraflor) on remineralization of enamel White Spot Lesions in permanent teeth of&#xD;
      adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a randomized controlled double-blinded study conducted on participants aged&#xD;
      10 to 24 years satisfying the inclusion criteria with visible active white spot lesions on&#xD;
      buccal surfaces of permanent teeth. Sixty six patients will be randomly allocated into 3&#xD;
      groups of the three materials: study group 1: one application of Curodont Repair, study group&#xD;
      2: one application of Nano-silver fluoride varnish and Control group twice application of&#xD;
      Fluoride Varnish (Duraflor).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 5, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 5, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the activity status of lesions scored using ICDAS-LAA</measure>
    <time_frame>12 months</time_frame>
    <description>Change in the activity status of lesions scored using ICDAS-LAA from baseline to final follow up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in mean DIAGNOdent readings.</measure>
    <time_frame>12 months</time_frame>
    <description>Change in mean DIAGNOdent readings from baseline to each follow up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbial count of mutans streptococci, lactobacilli.</measure>
    <time_frame>6 months</time_frame>
    <description>Microbial count of mutans streptococci, lactobacilli.from baseline to each follow up period</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>White Spot Lesion</condition>
  <arm_group>
    <arm_group_label>self-assembling peptide (P11-4)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Curodont Repair; Credentis will be applied to the&#xD;
white spot lesion at baseline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nanosilver fluoride varnish</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(Study group) Nano-silver fluoride varnish will be applied to the&#xD;
white spot lesion at baseline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sodium fluoride varnish</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>(Control group) Fluoride varnish (Duraflor) will be applied to the&#xD;
white spot lesion at baseline and 6 months follow up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>self-assembling peptide</intervention_name>
    <description>each Curodont Repair applicator unit contains both Curolox technology for guided enamel regeneration and water for activation of the device, each box contains 10 applicators</description>
    <arm_group_label>self-assembling peptide (P11-4)</arm_group_label>
    <other_name>Curodont repair</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>nanosilver fluoride varnish</intervention_name>
    <description>The synthesis of aqueous solution of silver nanoparticles will be carried out via the chemical reduction of silver nitrate (1 mL, 0.11 M) with sodium borohydride (0.3 mL, 0.8 M) and chitosan biopolymer (28.7 mL, 2.5 mg/mL) as a stabilizing agent. Sodium fluoride (10,147 ppm of fluorine) will be incorporated at the end of the experiment.</description>
    <arm_group_label>nanosilver fluoride varnish</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sodium fluoride varnish</intervention_name>
    <description>5% sodium fluoride varnish; One ml of fluoride varnish contains 50 mg of sodium fluoride in an alcohol-based suspension of resins.</description>
    <arm_group_label>sodium fluoride varnish</arm_group_label>
    <other_name>duraflor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1- An age range of 10-24 years ( age of young adolescents and youth as described by the WHO&#xD;
        was selected (WHO, 2019). 2. The presence of at least one visible WSL in the buccal surface&#xD;
        of permanent teeth with ICDAS II score of 1, or 2. 3. Completion of an informed consent to&#xD;
        participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. Patients receiving the following medications: tetracyclines, any other medication&#xD;
             known to stain teeth or any medication causing dry mouth and/or limiting salivary&#xD;
             flow. 2. Patients receiving any antibiotic within 1 month prior to each saliva sample&#xD;
             collection 3. Selected tooth with microcavities or dentinal involvement due to loss of&#xD;
             enamel tissues. 4. Selected tooth with a restoration adjacent to the lesions to avoid&#xD;
             false- positive readings. 5. Selected tooth with fluoride application &amp;lt; 3 months&#xD;
             prior to study treatment. 6. Selected tooth with discolouration, enamel hypoplasia or&#xD;
             fluorosis. 7. Patients with multiple cavitations to avoid variability in&#xD;
             microbiological analysis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hala A Amer, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Alexandria University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan M Saleh, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandria University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yara S Selim, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandria University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sara M Atteya, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandria University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of dentistry</name>
      <address>
        <city>Alexandria</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara M Atteya, MDS</last_name>
      <phone>01221094804</phone>
      <email>Sara.atteya@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 15, 2021</study_first_submitted>
  <study_first_submitted_qc>June 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Hams Hamed Abdelrahman</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Listerine</mesh_term>
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Sodium Fluoride</mesh_term>
    <mesh_term>Fluorides, Topical</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

